Digoxin use in atrial fibrillation: a critical reappraisal.
Center for Cardiovascular Innovation, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA; Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Sadiya S
SS
Khan
Center for Cardiovascular Innovation, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. Electronic address: m-gheorghiade@northwestern.edu.
Mihai
M
Gheorghiade
D000889:Anti-Arrhythmia Agents / Q000009:adverse effects*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000401:mortality*; D004077:Digoxin / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male
D000889:Anti-Arrhythmia Agents; D004077:Digoxin